Company / Cash per Share
Black Diamond Therapeutics, Inc. Cash per Share History
FY2019-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$15.47
FY2020
5-year range
$15.47 / $71.15
FY2019-FY2020
Trend
-78.3%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
15.47 in FY2020.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, cash per share decreased 78.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.60 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $15.47 | -78.3% |
| FY2019 | $71.15 | - |
As of FY2020 · SEC Form 10-K · Last checked Jun 21, 2026